NYSE:BME

BlackRock Health Sciences Trust (BME) Stock Price, News & Analysis

$40.01
+0.16 (+0.40%)
(As of 05/7/2024 ET)
Today's Range
$39.86
$40.01
50-Day Range
$38.45
$42.54
52-Week Range
$35.53
$42.86
Volume
23,617 shs
Average Volume
32,537 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
6.37%
Price Target
N/A
BME stock logo

About BlackRock Health Sciences Trust Stock (NYSE:BME)

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.

BME Stock Price History

BME Stock News Headlines

The Next Nvidia?
The Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that’s all they’ll talk about.
BME: Historically One Of The Best Times For Entry
The Next Nvidia?
The Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that’s all they’ll talk about.
Blackrock Health Sciences Trust's Dividend Analysis
BME - BlackRock Health Sciences Trust
Blackrock Health Sciences Trust (NYSE: BME)
See More Headlines
Receive BME Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BlackRock Health Sciences Trust and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 4/30 Dividend
4/12/2024
Dividend Payable
4/30/2024
Today
5/07/2024
Ex-Dividend for 5/31 Dividend
5/14/2024
Dividend Payable
5/31/2024

Industry, Sector and Symbol

Industry
Asset Management
Sub-Industry
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$20.41 million

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

BME Stock Analysis - Frequently Asked Questions

How have BME shares performed in 2024?

BlackRock Health Sciences Trust's stock was trading at $40.46 on January 1st, 2024. Since then, BME shares have decreased by 1.1% and is now trading at $40.01.
View the best growth stocks for 2024 here
.

Are investors shorting BlackRock Health Sciences Trust?

BlackRock Health Sciences Trust saw a decrease in short interest in April. As of April 15th, there was short interest totaling 4,500 shares, a decrease of 48.9% from the March 31st total of 8,800 shares. Based on an average trading volume of 30,800 shares, the short-interest ratio is presently 0.1 days.
View BlackRock Health Sciences Trust's Short Interest
.

How often does BlackRock Health Sciences Trust pay dividends? What is the dividend yield for BlackRock Health Sciences Trust?

BlackRock Health Sciences Trust announced a monthly dividend on Wednesday, May 1st. Shareholders of record on Wednesday, May 15th will be paid a dividend of $0.213 per share on Friday, May 31st. This represents a $2.56 dividend on an annualized basis and a yield of 6.39%. The ex-dividend date is Tuesday, May 14th.
Read our dividend analysis for BME
.

Is BlackRock Health Sciences Trust a good dividend stock?

BlackRock Health Sciences Trust (NYSE:BME) pays an annual dividend of $2.55 per share and currently has a dividend yield of 0.06%.
Read our dividend analysis for BME.

What ETF holds BlackRock Health Sciences Trust's stock?

Invesco CEF Income Composite ETF holds 125,790 shares of BME stock, representing 0.69% of its portfolio.

What is Javier Hernani Burzako's approval rating as BlackRock Health Sciences Trust's CEO?

3 employees have rated BlackRock Health Sciences Trust Chief Executive Officer Javier Hernani Burzako on Glassdoor.com. Javier Hernani Burzako has an approval rating of 100% among the company's employees. This puts Javier Hernani Burzako in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of BlackRock Health Sciences Trust own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BlackRock Health Sciences Trust investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), AT&T (T), Gilead Sciences (GILD), International Business Machines (IBM), Johnson & Johnson (JNJ), Verizon Communications (VZ), Exxon Mobil (XOM), Alibaba Group (BABA) and Procter & Gamble (PG).

Who are BlackRock Health Sciences Trust's major shareholders?

BlackRock Health Sciences Trust's stock is owned by a number of institutional and retail investors. Top institutional investors include Nova R Wealth Inc. (0.00%), Cambridge Investment Research Advisors Inc. (0.00%), Commonwealth Equity Services LLC (0.00%), Janney Montgomery Scott LLC (0.00%), NBC Securities Inc. (0.00%) and PFG Investments LLC (0.00%).
View institutional ownership trends
.

How do I buy shares of BlackRock Health Sciences Trust?

Shares of BME stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:BME) was last updated on 5/8/2024 by MarketBeat.com Staff

From Our Partners